Altimmune Inc’s recent filing unveils that its Director Drutz David unloaded Company’s shares for reported $0.11 million on Aug 19 ’24. In the deal valued at $6.90 per share,16,011 shares were sold. As a result of this transaction, Drutz David now holds 41,958 shares worth roughly $0.26 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guggenheim downgraded its Altimmune Inc [ALT] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in late January with a ‘”a Neutral”‘ rating. Goldman also remained covering ALT and has decreased its forecast on March 22, 2023 with a “Neutral” recommendation from previously “Buy” rating. Goldman started covering the stock on December 01, 2022. It rated ALT as “a Buy”.
Price Performance Review of ALT
On Monday, Altimmune Inc [NASDAQ:ALT] saw its stock fall -5.10% to $6.14. Over the last five days, the stock has lost -14.72%. Altimmune Inc shares have fallen nearly -45.42% since the year began. Nevertheless, the stocks have risen 145.60% over the past one year. While a 52-week high of $14.84 was reached on 02/28/24, a 52-week low of $2.09 was recorded on 08/05/24. SMA at 50 days reached $6.66, while 200 days put it at $8.13.
Levels Of Support And Resistance For ALT Stock
The 24-hour chart illustrates a support level at 5.95, which if violated will result in even more drops to 5.76. On the upside, there is a resistance level at 6.43. A further resistance level may holdings at 6.73. The Relative Strength Index (RSI) on the 14-day chart is 38.08, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.73, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 96.13%. Stochastics %K at 13.64% indicates the stock is a buying.
How much short interest is there in Altimmune Inc?
A steep rise in short interest was recorded in Altimmune Inc stocks on 2024-09-13, growing by 0.17 million shares to a total of 21.87 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 21.7 million shares. There was a rise of 0.79%, which implies that there is a positive sentiment for the stock.
